Search

Stradling

Ligand Pharmaceuticals Purchases Royalty Rights From Selexis SA

Ligand Pharmaceuticals Incorporated

Represented Ligand Pharmaceuticals Incorporated in its purchase of $4.5 million of royalty and milestone payment rights from Selexis SA.

Founded in 1987 as a cutting-edge drug discovery biotech in La Jolla, California, Ligand Pharmaceuticals has built a rich heritage of drug discovery and development innovation.